ACS medicinal chemistry letters

ACS Med Chem Lett · ISSN (print) 1948-5875 · 11 papers in corpus
other 2025
doi:10.1021/acsmedchemlett.5c00283 ·PMID:40529053

This patent presents novel substituted tetrahydrocyclohepteneindole derivatives as selective estrogen receptor alpha (ERα) inhibitors. These compounds demonstrate potential for treating Erα-related diseases such as cancers, ovulatory dysfun…

2024
doi:10.1021/acsmedchemlett.4c00150 ·PMID:39140045

AKR1C3 is an upregulated enzyme in prostate and other cancers; in addition to regulating hormone synthesis, this enzyme is thought to play a role in the aggressiveness of tumors and in the defense against drugs. We here used an unbiased met…

2021
doi:10.1021/acsmedchemlett.0c00559 ·PMID:33738067

SIRT1, a member of the sirtuin family, catalyzes the deacetylation of proteins with the transformation of NAD+ into nicotinamide and 2'-O-acetyl-ADP-ribose. Selective SIRT1/2 inhibitors have potential application in the chemotherapy of colo…

2021
doi:10.1021/acsmedchemlett.1c00545 ·PMID:34795853
other 2018
doi:10.1021/acsmedchemlett.8b00058 ·PMID:30034593

The progesterone receptor (PR) plays an important role in various physiological systems, including female reproduction and the central nervous system, and PR antagonists are thought to be effective not only as contraceptive agents and abort…

article 2016
doi:10.1021/acsmedchemlett.6b00184 ·PMID:27994732

We report here development of N-(4-phenoxyphenyl)benzenesulfonamide derivatives as a novel class of nonsteroidal progesterone receptor (PR) antagonists. PR plays key roles in various physiological systems, including the female reproductive …

2014
doi:10.1021/ml5003508 ·PMID:25516786

An efficient method for the direct labeling of the Arg guanidinium group in native peptides is reported. This straightforward procedure allows modifying the arginine moiety in peptides with various reporter groups, such as fluorophores, bio…

2014
doi:10.1021/ml5000417 ·PMID:24900886

Inhibition of VEGFR-2 signaling pathway has already become one of the most promising approaches for the treatment of cancer. In this study, we describe the design, synthesis, and biological evaluation of a new series of naphthamides as pote…

2014
doi:10.1021/ml5004469 ·PMID:25516782
2011
doi:10.1021/ml200093v ·PMID:21927646

17β-Hydroxysteroid dehydrogenase type 1 (17β-HSD1) represents a promising therapeutic target for breast cancer treatment. To reduce the undesirable estrogenic activity of potent 17β-HSD1 inhibitor 16β-(m-carbamoylbenzyl)estradiol (1) (IC(50…

2011
doi:10.1021/ml100220b ·PMID:24900294

We report the synthesis and characterization of novel 3-aryl indoles as potent and efficacious progesterone receptor (PR) antagonists with potential for the treatment of uterine fibroids. These compounds demonstrated excellent selectivity o…